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Chapter 1: Introduction to photochemistry of proteins

The study of photochemistry observes the electronic changes that occur when a
molecule absorbs a photon of light and the interactions that the active molecule has with
other molecules. This information can be used to create a wide array of applications
including solar cells,1 biomedical applications such as protein cleavage2 and
photodynamic therapies,3 as well as industrial applications such as automotive
coatings4. The following chapter highlights some of the basic principles and uses for
photochemistry.

1.1 Basics of photochemistry
Photochemistry is governed by two main laws. The first law of photochemistry,
Grotthus-Draper law, indicates that for a photochemical reaction to occur a photon of light
must be absorbed by a molecule.7,7 Most photochemical reactions are completed at
wavelengths in the visible light region of the electromagnetic spectrum (Figure 1) 5. The
electromagnetic spectrum orders wavelengths of light in terms of their photon energies
and the visible range consists of the wavelengths between 400-750 nm. The wavelengths
in this region are responsible for the colors observed by the human eye, which are a direct
result of the transmitted wavelengths of white light that are not absorbed by an object. 5
Additionally, this region is useful to photochemical reactions because it allows for
increased specificity of the reaction. If the chemical species of interest does not absorb
light at the wavelength of interest, no reaction will occur.

1

Figure 1: Electromagnetic Spectrum.

The probability (rate) of a photon being absorbed by a molecule is governed by
two principles; Beer law and Lambert law. Beer law states that the concentration of the
solution is proportional to the amount of radiation that is absorbed. Lambert law states
that the fraction of incident radiation (power) that is absorbed by the medium is
independent of the intensity of the incident radiation and, that each cross section of the
medium will absorb an equal fraction of the incident light; that the absorbance is
proportional to the light path. Combined together, Beer-Lambert law can be used to
derive equation 1.7
𝐴 = 𝜀𝑏𝐶

eq. (1)

Where A is the absorbance, ε is the molar absorptivity (L mol-1 cm-1); a constant that
denotes how well a substance absorbs light, b is the path length of the cuvette, and C is
the concentration. The absorbance value needed can be obtained using absorbance
spectroscopy, which measures the absorbance of a sample as a function of wavelength.6
To maintain the linear relationship between the variables the absorbance value of the
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dilute solution needs to be between 0.1 and 1. Using too concentrated of a solution can
cause shift in the spectrum.
The second law of photochemistry (Stark-Einstein law) states that for each photon
(quantum) of light absorbed, only one molecule is activated.7

When photons are

absorbed by the system, a transition from a lower energy to a higher energy state occurs.
The efficiency of the reaction is called the quantum yield.
While in this higher energy (excited) state, various chemical and physical
processes can occur. The electronic states and the various transitions that can occur are
schematically represented using a Jablonski (energy level) diagram (Figure 2).

Figure 2: Jablonski diagram. S0 indicates the ground state, S1 is the first singlet excited state, S2 is the second singlet
excited state, T1 and T2 is the triplet excited states8

In the Jablonski diagram, S0 denotes the ground (lowest) energy state and S n and T1
(Figure 3, bold horizontal lines) denote the singlet and triplet excited (higher) energy
states.8 The designation between the singlet and triplet states and what makes one more
3

accessible than the other is based upon the pairing of the electrons (Figure 3). In the
Singlet excited state, all of the electrons are paired and the Pauli exclusion principle is
upheld.5,6 In the triplet state, the electrons are no longer paired, they are parallel. Since
the Pauli exclusion principle is no longer upheld, the transition is considered “forbidden”.

Figure 3: Electron spin configurations of the different Energy states as related to the Jablonski diagram.

Within the different energy states, several vibrational levels exist (non-bolded horizontal
lines). Radiative processes, such as fluorescence are denoted with vertical bold lines.
Non-radiative processes, such as inter-system crossing, are denoted with vertical dotted
lines. These processes do not require the transfer of energy.
Radiative processes such as absorbance or fluorescence are processes in which
a photon’s energy is transferred to the electrons in a molecule. Many radiative processes
provide photophysical information that is useful to characterizing a molecule. This is due
to their non-destructive nature; the reactions are fast and concentration dependent,
emitting or absorbing energy at an amount equal to that of the energy associated with the
difference between the ground and excited states.9,15

Radiative processes include

absorbance, fluorescence, and phosphorescence. Absorbance is a process in which a
photon of light is captivated by a molecule, sending electrons from the ground state to the
vibrational levels of the singlet excited states (Figure 2, blue arrow). Fluorescence (Figure
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2, yellow arrow), is the opposite of absorbance. Instead of absorbing photons of light,
sending the molecule into the excited state, the excited electrons are emitted, sending
them back towards the ground state. The intensity at which the light is emitted from the
sample is proportional to the intensity of the incident radiation. The other main radiative
process is phosphorescence (Figure 2, red arrow), where light is emitted from the
molecule on a slower time scale because the return to the ground state from the triplet
state is spin forbidden.8
Conversely, nonradiative processes such as internal conversion or intersystem
crossing are transitions that redistribute the available energy.9

Internal conversion

(Figure 2, green wavy arrow) occurs as a result of vibrational relaxation to the lowest
excited state level, a necessity to uphold Kasha’s rule.10 Intersystem crossing involves
the transition from the excited single state to the excited triplet state (Figure 2, dark green
wavy arrow), changing the spin multiplicity. Conversion to the triplet state also provides
the necessary energy to obtain some photochemical products.
Unlike light activated photochemical reactions, thermal reactions require a change
in temperature change the energy therefore, do not require a light source to initiate the
reaction.7 Furthermore, thermal chemical reactions focus on the exchange of energy
between the sample and its surroundings (endothermic and exothermic). Opposite of
photochemical reactions, the temperature has a significant effect on the rate of reaction.

1.2 Model Protein

5

Serum Albumin (SA) was utilized as a model protein because it is inexpensive,
abundant, and well characterized.

This 66 kDA protein (Figure 4) is a waste product of

the meat industry.11 Its major function is as a carrier protein in the circulatory system
giving it the ability to bind numerous small molecules, fatty acids, metal ions, amino
acids, peptides, and hormones.12 This heart shaped protein is made of three
homologous domains each with the ability to support hydrogen bonding, electrostatic
interactions and hydrophobic interactions.13,14 Furthermore, it also contributes to the
overall colloidal osmotic pressure, the pressure exerted by proteins in blood plasma.15

Figure 4: Crystal structure of Bovine Serum Albumin (BSA) (PDB ID: 3VO3).15

1.3 Applications of photochemical reactions

6

There a wide variety of applications that utilize light to initiate or terminate the
reaction due to its benign reaction conditions. Several applications that are relevant to
protein are outlined below.
1.3.1: Protein photocleavage

Reagents with the ability to photocleave protein have a wide variety of applications
including structural investigations,16 therapeutic design,17 or footprinting ligand binding
sites on large biological structures.18 Use of light to initiate and terminate these reactions
not only provides an element of control over the reaction but, does not create harmful
byproducts because it is a “green” reagent.19 A further advantage to this method is its
ability to be completed in solution, providing insight into the relevant structures of
biomolecules in this phase.
In designing a photocleaving agent several factors need to be considered,
including the size and shape reagent, its hydrogen bonding capabilities, chirality, and
charge. These features work together to selectively bind one site on a protein, minimizing
the number of protein fragments created.

The approach to synthesize these

photoreagents is based on the assumption of ‘Complementarity’, in which the features of
the photocleaving reagent should “complement” the binding site of the target protein. 19
The design of Py-Phe (Figure 5) features several structural aspects that are necessary
for protein photocleavage reaction to occur.

Py-L-Phe, a photocleaving reagent, has

both hydrophobic and hydrophilic regions that are separated by a short peptide linker.
These features work in concert to provide specificity for the binding site. The hydrophobic
and hydrophilic regions are composed of a pyrenyl chromophore (Py) that would be
7

buried within the protein and a Phenylalanine (Phe) residue that would reside at the
protein/solution interface as a recognition element. The 6 atom linker region serves to
connect the two moieties while keeping them separate enough that they fulfill the
requirements of the binding site.17 The chromophore needs to be carefully chosen to
ensure that photons of the desired wavelength are absorbed ensuring the initiation of the
reaction. Pyrene has a high extinction coefficient in the near UV region (>40,000 M -1cm1

at 343 nm).19 Carbodiimide chemistry was used to put the three components together.

In a normal EDC coupling reaction, the primary amines are covalently attached to
carboxylic acids with the help of a coupling agent.20

Figure 5: Structural features of Py-L-Phe.

Organic photocleaving agents like Py-Phe and its various derivatives (Scheme 1)
have strong absorption in the near visible region, a long lived excited state, and high
affinity for hydrophobic sites on proteins, making it an excellent reagent for protein
photocleavage at a single site.17

8

Scheme 1: Py-Phe and its derivatives. Binding constants (M-1) for the probe binding to BSA are listed in blue.

Each molecule within this family of photocleaving agents has the ability to selectively bind
to BSA and cleave it. However, each derivate has different binding abilities that affect the
cleavage yields. Within the family of agents there molecules with reversed charge,
different recognition elements, different linker lengths, and varied chirality. The binding
abilities of each molecule provides insight to the contribution of the different pieces of the
reagent. For example, the difference between the binding constants for Py-L-Phe and
Py-D-Phe indicate the importance of the chirality of phenylalanine (the recognition
element). Also, based on the 10 fold decrease in the binding abilities of PMA-L-Phe and
PMA-D-Phe, it can also be concluded that the charge of the molecule is also important.
Lastly, experiments in which the linker length is systematically changed indicates that the
length is also important.2 Analysis of the ligands shows that most of them bind to the
protein site non-competitively and, with single occupancy.
9

The reaction for protein photocleavage required the addition of a Co(III) metal
complex such as Co(III) Hexammmine (CoHA). Co(III) complexes are known to quench
the pyrene excited state and are needed in order to produce the necessary cation
radical.19 In a typical reaction, photoreagent, protein, tris-acetate buffer, and CoHA were
hit with 343 nm light for a desired time period. After the designated period of time, the
sample was removed from the light and analyzed with SDS/PAGE (Figure 6).

Figure 6:SDS/PAGE gel of BSA photoreaction. Lane 1: Molecular weight markers in kDa, Lane 2: BSA, Lanes 3-7:
BSA+Py-L-Phe+CoHA, all irradiated for 0 (dark control), 10, 20, 30 and 60 minutes, Lane 8: BSA, Lane 9 BSA+Py-LPhe, Lane 10: BSA + CoHA, Lanes 8-10 irradiated for 30 minutes

The cation radical formed during the reaction is hypothesized to cause hydrogen
atom abstraction from the peptide backbone, causing photocleavage to occur (Figure 7).
The mechanism for photocleavage was elucidated by synthesizing various derivatives of
Py-Phe as well as through flash photolysis studies. Cationic probes in which the polarity
of the amide bond was reversed, as a result of this reversal, the photoproduct yield was
<5%.19 Probes in which the linker length was changed and probes containing a different
recognition element also shows significantly less photoproduct as compared to Py-L Phe
and Py-D-Phe.2,17
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Figure 7: Proposed mechanism for protein photocleavage by Py-Phe and its derivatives.

Using a light activated cleavage agent it is possible to site specifically cleave protein. This
application is advantageous because it allows for simple binding site mapping and makes
larger proteins easier to sequence.

.
Figure 8: Computational modeling of the Py-Phe binding site on BSA

Computational modeling of Py-Phe bound to BSA (Figure 8) was completed and
was in good agreement with the experimental data determined through amino acid
sequencing.
11

Photocleavage of BSA by a photocleaving agent is well characterized with
computational and experimental methods. Using this same method (Figure 9) the binding
site for the fluorescent dyes on the protein nanoparticles and the cross link density of the
BSA proteins that make up the particles can be elucidated.

Figure 9: Possible scheme for photocleavage of BSA protein nanoparticle.

There is also the chance that the particle will not be evenly cleaved, at which case the
particle may form two fragments of different sizes. If the cleavage site is at a point in
which not all the cross-links are destroyed, no fragments may be observed. If that is the
case, it might take multiple reactions to see cleavage of the protein.

Chapter 2: Testing the photochemistry parameters of GlowDots

Photobleaching of a fluorophore is a dynamic process in which the molecule is
destroyed after exposure to an excitation light source.21 Commonly, this occurs when
the fluorophore undergoes a photo-oxidation reaction while in the singlet or triplet
excited state. Once a fluorephore molecule has been bleached, it no longer
participates in emission, thereby creating a loss in signal intensity.21 A low
photobleaching quantum yield indicates that several excitation-emission cycles are
necessary before a loss in signal occurs, indicating that the rate of intensity loss will be
12

slow.22 The goal of this study is to determine the photobleaching quantum yields of
GlowDots, to help support their experimental use as an imaging agent.

2.1 Introduction

The study of photobleaching is important for a number or reasons, mainly in order
to test the rate of fluorophore destruction in a sample. One application of a fluorescent
sample is as an imaging agent. Molecules of this nature require a low photobleaching
quantum yield to ensure that they will last for 2-3 hours at a time (a normal confocal
microscopy session). For the quantification of a photobleaching experiment, a common
method is chemical actinometry. A chemical actinometer is a system that has been well
characterized and for which the quantum yield is known. 23

The system should be

sensitive and thermally stable, with additional advantages being use of simple analytical
methods for analysis. These systems undergo light induced reactions that involve either
a reversible or irreversible chemical reaction, when irradiated with a specific wavelength
of light, allowing the user to directly observe the number of photons absorbed as a
function of time.

Commonly, an actinometer is used to calibrate a detector or, to

determine the quantum yield for a photochemical reaction using equation 2. Specifically,
an actinometer can be used to determine the number of einsteins (photons per unit time)
for a photochemical reaction.
Φ=

𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑙𝑒𝑠 𝑐𝑜𝑛𝑠𝑢𝑚𝑒𝑑 𝑜𝑟 𝑝𝑟𝑜𝑑𝑢𝑐𝑒𝑑 𝑝𝑒𝑟 𝑢𝑛𝑖𝑡 𝑡𝑖𝑚𝑒
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑛𝑠 𝑎𝑏𝑠𝑜𝑟𝑏𝑒𝑑 𝑝𝑒𝑟 𝑢𝑛𝑖𝑡 𝑡𝑖𝑚𝑒

eq (2)

Tris (2, 2’-bipyridyl) ruthenium(II) chloride (Ru(bpy)3Cl2) (Figure 10A), a
precious metal catalyst, can be utilized as a chemical actinometer within the visible light
13

spectrum for calibration of a light source. Use of the visible portion of the electromagnetic
spectrum uses milder conditions, allowing for a “greener” reaction.24

Additionally,

Ru(bpy)3Cl2 is a diamagnetic molecule with a long lived excited state lifetime. Utilization
of the singlet oxygen chemistry Ru(bpy)3Cl2 is well known allows the actinometer to
monitor the oxidation of 1,9-diphenlyanthracene (DPA) (Figure 10B) to its corresponding
endoperoxide using Uv/Vis spectroscopy. The oxidation reaction is monitored specifically
because the corresponding peak is not obscured by the metal-to-ligand charge transfer
band of the Ru(bpy)3Cl2 . This system was chosen instead of the well-known ferrioxalate
actinometer because of its ease of use.

A)

B)

Figure 10:Strucutres of Ru(bpy)3Cl2 and DPA.

Photodynamic therapy (PDT) is a type of cancer treatment that uses light and
oxygen to damage cells, sending them into apoptosis.25,26 In this system, singlet
oxygen is produced upon the interaction of the light beam with a photosensitizer,
commonly a fluorescent dye, creating free radicals which has a destructive effect on
cells. In the absence of light, PDTs are benign.34 In a normal treatment, the PDT is
injected into the diseased tissue in the first step and exposed to a specific wavelength of
light in the second.27 The main limitations of this methodology include low tumor
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targeting efficacy and poor water solubility.34 However, use of nanoparticles, micelles,
and other types of nanomaterials have been integral in overcoming these issues.
GlowDots are made from bovine serum albumin (BSA), a waste product from the
meat industry. BSA is also non-toxic28 and has been approved by the Food and Drug
Administration for medicinal applications; making it an excellent material for biological
nanotechnologies. This protein is also natural drug-delivery vehicle that has the capability
to bind a number of small molecules, dyes, peptides, hormones, and drugs.29 BSA has
99 COOH groups from glutamate and aspartate residues, and 59 amine groups from
lysine side chains which can be used for self-crosslinking to build particles of any desired
size. Furthermore, any leftover amine and carboxyl groups as well as other surface
functions can be used for the exquisite control of particle surface chemistry, unlike QDs
which require surface passivation and modification.30 GlowDots do not require any
specialized modification of their surface to be soluble in aqueous solutions, unlike QDs
or polymer nanoparticles.
In the current studies, we have examined the quantum yields of emission and
quantum yields of photodegradation of GlowDots, which are reported in this chapter.

2.2 Experimental
2.2.1 nBSA Synthesis
Protein solution was prepared by stirring 150 mg of BSA in 1 mL of de-ionized
water (dH2O). EDC (1M, dH2O) was added in 10 mM aliquots and stirred for 20 min
between additions. Particle growth was monitored by dynamic light scattering (DLS).
Reaction was quenched by adding 2 mL of 20 mM CO 32-/HCO3- pH 9.3 buffer. Sample
was then diluted into 100 mM Phsophate 150 mM Sodium Chloride buffer pH 7.0 and
15

heated to 85 C for 10 minutes. Solutions were allowed to cool back to room temperature.
Taurine powder was added to the nanoparticle solution (100x concentration of protein)
and 100 mM EDC added dropwise to the solution. This was allowed to stir for 30 min. A
solution of fluorescent dye, (0.5 % (w/w)) in DMSO was added to the protein solution and
stirred for 4 h in the dark at room temperature. Samples were filtered in Amicon 100 kDa
cutoff centrifuge filter tubes with 10 mM Na2HPO4 pH 7.0 buffer until filtrate was clear of
fluorescent dye evidenced by absorption spectrum of the run through (approximately 10
x sample volume). This method was repeated for making all 6 varieties of GlowDots: 1Pyrene

butanoic

acid

(340),

7-methoxycoumarin-3-hydroxy

(350),

Diethylaminocouramine-3-carboxylic acid (432), fluorescein isothiocyanate (494),
tetramethylrhodamine

-5-(and-6)-isothiocynate

(543),

and

5-(and-6)-carboxy-x-

rhodamine (576). All samples were denoted as GlowDotX where X is the emission
wavelength of the dye.
2.2.2. Absorbance measurements
Absorption spectra were measured on an HP 8450 diode array spectrophotometer
(Varian Inc., Santa Clara, CA). Samples were diluted in 10 mM Na2HPO4 pH 7.0 and the
baseline averaged from 700-900 nm was subtracted.
2.2.3. DLS measurements
Hydrodynamic radius of GlowDots was monitored by photon correlation spectroscopy
with Precision Detectors (Varian Inc., part of Agilent Technologies), CoolBatch+ dynamic
light scattering apparatus with 1 x 1 cm2 square plastic cuvette and a 658 nm excitation
laser source with a 90 geometry. Data collection was done at room temperature, for 1 s,
3 repetitions with 200 accumulations. All samples were filtered with 0.22 m filter (PDVF,
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13 mm, Restek). Precision Ellucidate v 1.1.0.9 and Precision Deconvolve v 5.5 were used
to collect and analyze the data respectively.
2.2.4. Transmission electron microscopy measurements

GlowDots solution (1 ng/mL) was applied to a carbon-coated Cu grid (400-mesh) and
blotted with filter paper (Whatman #4).

After an hour of drying, the grids were imaged

using a Techni T12 S/TEM.
2.2.5. Agarose gel
Agarose gels were prepared by dissolving agarose (0.5 % w/v, Sigma electrophoresis
grade) in heated Tris acetate (40 mM, pH 7.0). The gel was poured on a horizontal
electrophoresis apparatus (Gibco model 200, Life Technologies Inc., MD) and Tris
acetate (40 mM, pH 7.0) was used as the running buffer. Samples were loaded into the
wells at the center of the gel with 50 % (v/v) loading buffer (50 % v/v glycerol, 0.01 % m/m
bromophenol blue). Electrophoresis was carried out for 30 min at 100 mV at room
temperature. The gel was stained overnight with 0.02 % m/m Coomassie Blue, 10 % v/v
acetic acid and then destained overnight with 10 % v/v acetic acid.
2.2.6. Photobleaching experiments
To determine the photobleaching quantum yields of each of the particles, samples
were irradiated using a monochrometer and tested against a standard. Standards used
in the experiment were Ru(bpy)3Cl2 actinometer or free dye in solution. Samples were
irradiated until a 10% loss in absorbance was observed.

Wavelengths used were

standard confocal laser lines (405 nm, 488 nm, and 561 nm). In the cases where the dye
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conjugated to the surface of the protein did not absorb in any of those regions, 340 nm
and 365 nm were used. Before irradiation, the standard was matched to the sample of
interest at the aforementioned wavelengths to ensure that the same number of photons
were present.
2.2.7. Circular Dichroism
CD spectra were measured on a Jasco J-710 CD spectrometer. A concentration
of 3 M protein in 10 mM Na2HPO4 buffer pH 7.0 was used. Spectra were obtained
using a 0.05 cm path length quartz cuvette in the region of 260 – 195 nm. Other
operating parameters were: sensitivity 100 mdeg, data pitch 0.5 nm, continuous
scanning mode, 50 nm/min scanning speed, 1 s response, 1.0 nm bandwidth and 3
accumulations. CD spectra were corrected by subtracting buffer signal from sample
signal. Enzyme structure retention was assessed by calculating the change in ellipticity
where BSA in 10 mM Na2HPO4 buffer pH 7.0 was taken as 100 % ellipticity.

2.3 Results/Discussion

In this method, the carboxylic groups of bovine serum albumin (BSA) molecules
were cross-linked with the amine groups of neighboring BSA molecules. Particle
formation was monitored via dynamic light scattering (DLS). Once 60% or more of the
particles reached 35 nm diameter, the particle formation was quenched with the addition
of carbonate buffer. To achieve a monodispersed size, particles were annealed at 85 ⁰C
for 5 minutes. Protein nanoparticles were then decorated with reactive fluorescent labels
to provide them with a tunable emission. Final products were characterized by DLS,
agarose electrophoresis, TEM, circular dichroism, as well as, absorbance spectroscopy.
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Subsequently, each particle was named using the term ‘GlowDot’ and the peak
absorbance wavelength associated with the attached dye. For example, protein
nanoparticles labeled with fluorescein isothiocyanate are designated as GlowDot494.
2.3.1. Synthesis of nBSA

To synthesize the protein nanoparticles (GlowDots) used in the photochemical
studies carbodiimide chemistry was used to slowly cross-link carboxylic acid and primary
amines from a 150 mg/mL BSA solution together using 1 M EDC (Figure 1).

Figure 11: Synthesis of GlowDot protein nanoparaticles.

Throughout the synthesis, dynamic light scattering (DLS) was used to check the
size of the particles. An aliquot of the 10 mM EDC was added to the BSA solution every
20-30 minutes until the DLS showed sizes of 9 nm and 40 nm. At this point, the solution
was quenched by adding 2x the sample volume of 100 mM phosphate, 500 mM sodium
chloride buffer, pH 7.2 and the size distribution was allowed to equilibrate for 24 hours to
obtain a 50/50 distribution of 9 and 35 nm. To achieve a monodispersion of particles, the
sample was diluted to 1 mg/mL and heated at 85˚C for 5 minutes. After cooling to room
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temperature, the particles were labeled with 0.5% w/w of one of six reactive fluorescent
dyes (Table 1) and allowed to stir in the dark, at room temperature for 4 hours. To purify
the samples, filter centrifugation was utilized to remove any free dye, free protein, or salt
from the solution. Samples were washed with 10 mM phosphate buffer, pH 7.2 until the
run through showed no absorbance peak at 280 nm.

Table 1: Fluorescent dyes used in the synthesis.

2.3.2. Characterization of nBSA
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To characterize the GlowDot samples, several techniques were used. To better
understand the optical properties of the particles, absorbance spectroscopy was used.
All of the particles show a change in the dye absorbance peak in comparison with the free
dye (Figure 12A). GlowDot340 and GlowDot543 had an additional peak while a peak
shift (compared to free dye) was observed for all other GlowDots. Changes in absorbance
spectra suggest that the dyes are buried inside the protein nanoparticle with limited
solvent exposure.

A)

B)

Figure 12: A) Absorbance spectra and .B) Fluorescence spectra of the GlowDot particles.

To demonstrate the size of the particles, DLS and transmission electron
microscopy (TEM) were used. All particles were annealed to have a size of approximately
40-50 nm, which closely matches particle sizes seen in the transmission electron
microscopy image of the protein nanoparticles (Figure 13B). A single size distribution was
observed after purification of the nanoparticle that was labeled with a reactive fluorescent
dye.
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50 nm

Figure 13: A) DLS of GlowDot particles B) TEM of GlowDot particles

Agarose gel electrophoresis was used to confirm that the reactive
fluorescent dye is actually binding to the protein.

Agarose gel electrophoresis of

GlowDot340, GlowDot350, GlowDot432, GlowDot494, GlowDot543 and GlowDot576
initially imaged using UV light (254 nm, Figure 14A) clearly show five fluorescent bands
directly matching the protein bands viewed in the coomassie stained gel (Figure 14B).
The lack of a second fluorescent band in the lanes of the gel confirms there is no free dye
in the samples. All of the GlowDots migrated a shorter distance towards the positive
electrode compared to unreacted BSA. This is due to the increase in size of the particle
and the possibility of small changes in the net charge of the protein due to crosslinking.
While every conjugation event consumes a positively charged amine and a negatively
charged carboxylic acid, resulting in no net change in overall charge, cross-linking could
result in the exposure of residues that are normally buried, hence changing the net charge
of the protein.
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A)

B)

Figure 14: A) Agarose gel electrophoresis (160 mM Tris Acetate, pH 8.0) demonstrated the decreased mobility of
GlowDot (lane 2) compared to BSA (lane 1). Addition of the fluorescent dyes 1-pyrenebutanoic acid, succinimidyl
ester (340), 7-methoxycoumarin-3-hydroxy (350), Diethylaminocouramine-3-carboxylic acid (432), fluorescein
isothiocyanate (494), tetramethylrhodamine -5-(and-6)-isothiocynate (543), and 5-(and-6)-carboxy-x-rhodamine (576)
(lanes 3-7 respectively). B) Coomassie Blue stain gel of fluorescent protein nanoaparticle gel in B.

2.3.3 Photobleaching Experiments

Photostability experiments were completed to ensure the stability of the particles
upon exposure to light. Most of the particles were photostable for at least 30 minutes.
GlowDot 494 and GlowDot543 were the most photostable, not losing 10% of their
absorbance intensity for 1 hour. GlowDot340, GlowDot350, and GlowDot432 was the
least photostable, losing 10% of their intensity in less than 10 minutes.
Photobleaching quantum yields were calculated using either Ru(bpy)3Cl2
actinometer or the free dyes in solution as standards to help quantify the light intensity.
GlowDot494 was calculated by determining the number of photons absorbed in the
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system using chemical actinometry. Actinometer used for experiments was Ru(bpy)3Cl2
as outlined by Pitre, et al. 2015.24 In a normal experiment, actinometer absorbance was
matched to GlowDots at a specific wavelength (340, 365, 405, 488,561 nm). After
matching, each sample was irradiated using a light beam passed through a
monochromator (Figure 15) for time increments ranging from 30 seconds-30 minutes
depending on the particle. Conversely, the actinometers were irradiated for increments
ranging from 5 seconds to 60 seconds.

A)

B)

Figure 15: A) Experimental set up for photobleaching quantum yield. A light beam is sent from the light source
through a monochromator set to a specific wavelength before passing through the sample. B) Schematic set-up

The particle intensity decrease was monitored by absorbance spectroscopy. In a
typical experiment, samples were irradiated at room temperature in the dark until a 10%
drop in the absorbance at the monitored wavelength was observed. In many cases,
photoirradiation caused chemical cross-linking of the particles. To remove these large
aggregates, samples were centrifuged at 10,000 rpm for 2 minute increments before
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taking the absorbance. Samples containing pyrene (Figure 16A and B) were monitored
at 340 nm. Methoxycoumarin (Figure 16C and D) were irradiated and monitored at 365
nm. Samples containing DEAC (Figure 16E and F) were irradiated and monitored at 405
nm. FITC samples (Figure 16G and H) were monitored at 488 nm. Samples containing
TRITC (Figure16I and J) and ROX (Figure16K and L) both were monitored at 561 nm.

A)

B)

C)

D)
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E)

F)

G)

H)

I)

J)
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K)

L)

Figure 16: Absorbance spectra from the photobleaching experiments. A) Free 1- Pyrenebutanoic acid, succinimdyl
ester B) GlowDot340 C) Free 7-Methoxycoumarin-3-carboxylic acid, succinimidyl ester D) GlowDot350 E) Free 7diethylaminocoumarin-3-carboxylic acid, succinimdyl ester F) GlowDot432 G) Ru(bpy)3Cl2/DPA H) GlowDot494 I)
Free Tetramethyrhodamine-5-(and 6)- isothiocyanate J) GlowDot543 K) Free 5-(and 6)- Carboxy-X-rhodamine,
succinimidyl ester L) GlowDot576

Using the absorbance data and equations 3-5,2424 the photobleaching quantum
yields could be calculated. First, the moles decomposed by irradiation of the sample need
to be calculated (eq. 3).
# 𝑚𝑜𝑙𝑒𝑠 𝑐𝑜𝑛𝑠𝑢𝑚𝑒𝑑 =

𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒𝑖𝑛𝑖𝑡𝑖𝑎𝑙 −𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒𝐹𝑖𝑛𝑎𝑙
𝜀𝑙

∗ 𝑉 ……………………….. (eq 3)

Where Absorbanceititial is the absorbance value at the appropriate wavelength from the
matched samples, Absorbancefinal is the value at the same wavelength after the 10% drop
in intensity is absorbed, ε is the extinction coefficient calculated for the free dye at that
wavelength, l is the pathlength of the cuvette (1 cm) and, v is the volume of the sample
(0.6 mL). The dilution factor of the sample also needs to be considered. Next, to
determine the intensity of the light source equation 4 was used.
𝑁ℎ𝑣
𝑡

=

𝑚𝑜𝑙𝑒𝑠 𝑐𝑜𝑛𝑠𝑢𝑚𝑒𝑑
Φ𝑡

………………………………………. (eq 4)
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Where

𝑁ℎ𝑣
𝑡

is number of photons per unit time, moles consumed is the number calculated

in equation 3, Ф is the relative quantum yield of the free dye (table 2) or the calculated
quantum yield of Ru(bpy)3Cl2,24
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and t is the irradiation time in seconds. Finally, to

calculate the photobleaching quantum yield for the irradiated particles, equation 5 was
used.
Φ=

𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑙𝑒𝑠 𝑐𝑜𝑛𝑠𝑢𝑚𝑒𝑑 𝑜𝑟 𝑝𝑟𝑜𝑑𝑢𝑐𝑒𝑑
𝑡

𝑁ℎ𝑣 −1
)
𝑡

∗(

…………………….. (eq 5)

Where the number of moles consumed or produced was calculated using equation 3, t is
𝑁ℎ𝑣 −1
)
𝑡

irradiation time in seconds, and (

is the reciprocal of the value found in equation 4.

Table 2: Summary of photobleaching quantum yield data.

Sample

Photostability (Minutes) 10%

Relative

Photobleaching

loss

Quantum Yield

Quantum Yield

GlowDot

< 10 minutes (Irradiated at 340

37.0

0.22 ± 0.03

340

nm)

GlowDot

< 10 Minutes (Irradiated at 365

1.2

5.7 x 10-3 ± 0.01

350

nm)

GlowDot

< 10 minutes (irradiated at 405

12.7

0.3 ± 0.2

432

nm)

GlowDot

30 Minutes (irradiated at 488

0.4

5.5 x 10-3 ± 0.003

494

nm)

GlowDot

60 Minutes (irradiated at 561

1.6

3.1 x 10-3 ± 0.004

543

nm)
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GlowDot

25 Minutes (irradiated at 561

576

nm)

0.9

4.4 x 10-4 ± 1.5 x 10-4

Ideally, the lowest photobleaching quantum yield possible is going to be optimal.
After completing each measurement in triplicate, it was determined that GlowDot576 has
the lowest photobleaching quantum yield, 4.4 x 10-4 (Table 2 and Figure 17) which
indicates that its rate of photdestruction is the slowest.

The rate of fastest

photodestruction occurs with GlowDot432 (Table 2). The experimental value obtained
for GlowDot494 in 10 mM phosphate buffer, pH 7 is 5.5 x 10-3 which is comparable to
literature, in which the photodestruction quantum yield of free FITC in water at pH 9 is
1.2x10-4.31
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Figure 17: Graphical representation of photobleaching quantum yield measurements showing the standard error for
the triplicate measurements. The structure of the dye molecule is listed as well.

Overall, the values obtained in the study are in good agreement with the values
shown in literature. Furthermore, the primarily low values indicate that GlowDots would
be excellent for use in confocal microscopy because they would be able to sustain the
high intensity laser.
2.3.4. Analysis of irradiated products

Circular dichrosim was used to determine whether or not the native structure of
BSA was retained after irradiating the samples with certain wavelengths of light. The
30

structure of the BSA in GlowDots and the irradiated GlowDots were analyzed and
compared to free BSA to determine whether any of the secondary structure was lost due
to cross-linking. To normalize the protein concentrations of each sample a Bradford assay
was carried out.

A)

B)
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C)

D)
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E)

F)

Figure 18: Circular dichroism of GlowDot particles. All samples were diluted in 10 mM phosphate buffer, pH 7.0. A)
GlowDot340, B) GlowDot350, C) GlowDot432, D) GlowDot494, E) GlowDot543, F) GlowDot576.

As shown in Figure 18, irradiated samples show a significant loss in alpha helical
structure (less than 50%). By setting BSA to depict 100% ellipticity, structure retentions
for GlowDots and their irradiated counterparts were calculated using the signal intensity
at 220 nm. Non-irradiated GlowDot sample’s secondary structure retention of at least
50%. The irradiated samples showed structural retention < 50% (Table 3), indicating
that the samples were destroyed upon light irradiation. GlowDot350 showed the highest
amount of structural retention upon irradiation (47%) and GlowDot494 showed the least
amount of retention (31%).
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Table 3: Summary of the % structural retention calculated for the irradiated and non-irradiated samples of GlowDots.

Sample:

%
retention:

GlowDot340

45%

Irradiated

40%

GlowDot340
GlowDot350

53%

Irradiated

47%

GlowDot350
GlowDot432

53%

Irradiated

35%

GlowDot432
GlowDot494

61%

Irradiated

31%

GlowDot494
GlowDot543

46%

Irradiated

35%

GlowDot543
GlowDot576

52%

Irradiated

43%

GlowDot576

2.3.5 Cell uptake studies

To Test the ability of GlowDots as imaging agents, cell uptake studies have been
completed.47 To boost their ability to be taken up by cells, a taurine label was coupled to
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the nanoparticle surface. Taurine was chosen for this task because of its known ability to
increase uptake of D-peptides by cells tenfold.32 As shown in Figure 19, white emitting
particles were successfully taken into Hela cells. Based on the cell uptake studies and
the photobleaching studies, GlowDot particles have the potential to be useful as a PDT.

Figure 19: Overlay of red, green, and blue channels of HeLa cell uptake of nBSAW405 particles decorated with the
natural amino taurine and the cell under transmitted light.

Presently in literature, there are several serum albumin PDTs in the works.26,33,34
For example, in a paper by Preub, A. et al.26 Human serum albumin (HSA)
nanoparticles with diameter 100-300 nm were synthesized using a well-known solvation
method before being loaded with one of two porphyrin based photosensitizers (Figure
20) which are known to interact with organelles such as lysozomes, and
mitrochondria,.26
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A)

B)

Figure 20: Strucure of photosensitizers A) meta-tetra(hydroxy-phenyl)-cholin (mTHPC) and B) meta-tetra(hydroxyphenyl)-porphyrin (mTHPP).

The main experiments completed were to understand the drug release and phototoxicity
as a function of incubation time as well as to understand the uptake mechanism and
photophysical properties of the two systems in jurkat cells. To understand the uptake
mechanism, nanoparticle degradation and drug release were monitored with confocal
microscopy. They also investigated the ability of the photosensitizer molecules (Figure
20) to generate singlet oxygen. In their experiments, mTHCP loaded particles had a
higher phototoxicity than mTHPP loaded ones, based on a higher absorbance of the
excitation wavelength.26 mTHPC particles have a higher ability to produce singlet oxygen
due to its amphipathic nature it also has a faster release rate.
Based on the results shown above and the literature data, it may be possible to
use the protein particles to create a PDT. Based on the photostability data collected the
dyes embedded in the protein react with singlet oxygen to create free radicals in a
photooxidation reaction. These radicals then cause irreversible damage to the cell and
eventually leading to apoptosis.35 For the reaction to optimally occur, it important that the
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protein vehicle, in this case BSA, be in its monomeric form because induces an increase
in singlet oxygen production.36 By exchanging the visible range fluorescent dye currently
used on the GlowDot particle’s surface for a Near Infrared (NIR) dye, it would be possible
to create a PDT with a significant penetration depth. An organic NIR dye, like the visibile
range ones could be used as a photosensitizing agent. Furthermore, since BSA has the
ability to bind a large number of molecules, it is possible to attach a targeting agent to the
surface of the protein to increase specificity for tissues or cells of interest. It is necessary
to ensure that the targeting mechanism works correctly, so as to keep healthy cells from
being destroyed. If the experiments work, a novel PDT can be synthesized (Figure 19)
containing folic acid as a a specificity element, a NIR florescent dye as a photosensitizer
and, a biocompatible protein as a vehicle.

Figure 21: Reaction for synthesis of GlowDot494 conjugated with folic acid and taurine for cell uptake and selectivity.

One possible pathway would be to label the particles with folic acid to increase the
specificity for MCF-7 (breast cancer).37 Folate receptors overexpress at the surface of
cancer cells but produce low levels of folate in normal cells (such as A549), providing a
simple way to distinguish between the two types of cells.37,38,38

Using this cell targeting

method, the receptor-mediated endocytosis pathway can be used for uptake. 39

Upon

uptake, hitting the area with a light source would enact the PDT, killing the cells of interest
(Figure 22).
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Figure 22: Reaction Scheme of the possible mechanism for cell apoptosis with the proposed PDT. Red indicates a
healthy cell and Grey indicates a dead one.

2.4 Conclusions
Since the photochemical reaction was completed in the presence of oxygen, it can
be hypothesized that destruction of the fluorophore occurs as a result of a photooxidation
reaction. However, more experiments are needed to confirm the hypothesis. Circular
dichroism experiments show that adding a fluorescent dye to the protein nanoparticles
does not significantly affect the protein secondary structure. However, hitting the protein
nanoparticles with a concentrated light beam does significantly impact the secondary
structure. Additionally, most of the particles have low photobleaching quantum yields;
signifying that the rate of intensity loss is slow. This is further confirmed based on the
length of time for which the particles showed a 10% loss in the absorbance intensity at
peak associated with the confocal laser line. Most of the particles did not see a noticeable
change until 30-60 minutes of irradiation. Since a common confocal microscopy session
is 2-3 hours, it is likely that the particles would make decent imaging agents. Due to the
crosslinking of the particles observed upon irradiation, the method of photobleaching is
photooxidation. This is further supported based on the presence of oxygen during the
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experiment. This feature opens the particles up to a whole new realm of possible
applications, including use in photodynamic therapy.

Chapter 3: Towards the synthesis of protein nanoparticle
protected gold nanoclusters

One potential direction for the protein nanoparticles is to replace the reactive
fluorescent dye with gold nanoclusters. At their small size, gold nanoclusters fluoresce
in the near IR region, an advantageous trait for biological applications. Fluorescence in
the near IR region allows for a higher penetration depth and decreased background noise.

3.1 Introduction

Gold nanoclusters (AuNCs) are groupings of gold atoms held together by metalmetal bonds having a diameter of less than 3 nm. Within this realm of clusters exist gas
phase clusters, condensed (solution) phase clusters, and organometallic clusters.46 Due
to their small size, they usually require a capping agent, such as a protein or organic
ligand to keep them from aggregating together in solution.40 Furthermore, their electronic
properties differ from those associated with larger nanomaterials made of the same
metals. For example, AuNCs are not able to support the surface plasmon resonance
(SPR) band that is associated with bulk gold and gold nanoparticles. The absence of this
band is due to the inadequate density of the gold atoms to merge the conduction and
valence bands (they are very close to the Fermi energy/ de Broglie wavelength). They
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also are able to exhibit size dependent fluorescence in the visible and near Infrared region
of the electromagnetic spectrum.
The emission wavelength of the nanoclusters are dependent on the number of
atoms that make up the gold nanoclusters and are proportional the Fermi energy of gold
(Efermi = 5.53 eV for gold). Using the spherical jellium approximation, the number of atoms
can be calculated using the equation Eemission = Efermi/N1/3 ; Where N is the number of
atoms per cluster.
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This model explains the relation between the delocalized free

conduction electron behavior relative to the atomic core size. 41 Literature indicates that
a wide range of cluster sizes have been formed experimentally; forming clusters made of
anywhere between 342 and 55 gold atoms and, emission wavelength is dependent on the
number of atoms present per cluster. Generally, as the size increases the fluorescence
emission red shifts, until the size of the clusters exceeds 30 atoms. At this point, the
clusters no longer are fluorescent. AuNCs have fluorescence emission wavelengths
ranging from 400 - Near IR range, where Au25 clusters have a fluorescence peak around
650-700 nm. Furthermore, photophysical properties of the clusters are also affected by
the pH, temperature and, capping agent used in the synthesis. The pH of the solution is
important for controlling the power of the reducing agent as well as the conformation of
the protein. The temperature is also important in controlling the reaction rate and the
conformation of the protein capping agent. Lastly, the capping agent is important to the
Ligand-metal-charge transfer (LMCT) that occurs. A capping agent capable of donating
a large number of electrons is optimal.
Chemical reduction, photoreduction, and chemical etching are the main ways to
synthesize AUNCs.43 Because they can be made in several fashions, they also have a
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wide variety of capping agents at their disposal, making them advantageous to a wide
realm of applications including detection and dual-modality imaging agents. Namely, that
the NIR emission of the particles gives them an increased penetration depth and deals
with less background noise. Furthermore, their ultrasmall size and low cytotoxicity are
additional advantages. Use of chemical reduction allows for the reduction of Au 3+ to Au0
with the help of a reducing agent, for example, Bovine serum albumin or sodium
borohydride.43
Among the many possible capping agents used in literature to stabilize the
clusters, Bovine serum albumin (BSA) is one of the most common.
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BSA is well

characterized and known to be nonhazardous. Other capping agents have also been
used to synthesis gold nanoclusters through chemical reduction including MES and other
small molecules,44 polymers,45 and other proteins.
Gold nanoclusters are of interest because of their high quantum yields41
nonphotobleachability as compared to organic fluorophores46 and, longer lifetime. 46 They
have the ability to be useful in several applications including catalysis, sensing, and drug
delivery.

3.2 Experimental

To characterize the BSA protected gold nanoclusters, herein called Au-nBSA,
DLS, Fluorescence and absorbance spectroscopy were used.
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3.2.1. Au-nBSA synthesis

Au-nBSA particles are synthesized using an abridged method of nBSA synthesis
in conjunction with a well-known synthesis for gold-BSA particles.40 In this method, nBSA
particles were cross-linked with EDC, quenched with 2x the volume of either Deionized
water or 100 mMphosphate 500 mM sodium chloride buffer (pH 7.2), and allowed to
equilibrate overnight.47 The sample was then diluted to 50 mg/mL and combined with an
equal volume of 10 mM HAuCl4 and a small volume of 1 M NaOH before being heated
overnight at 37˚C. After heating, the solution was centrifuged at 11,000 rpm for 15-20
minutes to remove large aggregates.

3.2.2. DLS

Hydrodynamic radius of Au-nBSA was monitored by photon correlation
spectroscopy with Precision Detectors (Varian Inc., part of Agilent Technologies),
CoolBatch+ dynamic light scattering apparatus with 1 x 1 cm2 square plastic cuvette and
a 658 nm excitation laser source with a 90 geometry. Data collection was done at room
temperature, for 1 s, 3 repetitions with 200 accumulations. All samples were filtered with
0.22 m filter (PDVF, 13 mm, Restek). Precision Ellucidate v 1.1.0.9 and Precision
Deconvolve v 5.5 were used to collect and analyze the data respectively.
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3.2.3. Absorbance Spectroscopy
Absorption spectra were measured on an HP 8450 diode array spectrophotometer
(Varian Inc., Santa Clara, CA). Samples were diluted in 10 mM Na2HPO4 pH 7.0 and the
baseline averaged from 700-900 nm was subtracted.
3.2.4. Fluorescence Spectroscopy
Fluorescence Spectra were recorded on Cary Eclipse Fluorimeter. All spectral
measurements were done in a 1 x 1 cm2 quartz cuvette.

3.3 Results/Discussion

Small introduction

3.3.1. Synthesis of Au-nBSA particles

To show the diverse possibilities that are available with nBSA, particles
containing gold nanoclusters were synthesized using a modified version of a well-known
BSA protected gold nanocluster method (Xie, J et al).40 Figure 23 illustrates the
synthesis. Using the protein nanoparticle synthesis described previously, 47 BSA is
cross-linked together and the reaction is quenched with either deionized water or 100
mM, 500 mM sodium chloride buffer, pH 7.2. After allowing the sample to equilibrate
overnight, 10 mM HAuCl4 is added to the solution and allowed to stir for 2 minutes
before the addition of 1 M NaOH, which gives BSA to act as a reducing agent for the
gold. The solution is then heated overnight to obtain a solution that is deep red in color.
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Figure 23: Synthesis of Au-nBSA.

3.3.2 Characterization of Au-nBSA

A)

B)

Figure 24: Difference between Centrifuged and noncentrifuged samples, A) Reaction quenched with Deionized water
B) Quenched with 100 mM phosphate, 500 mM sodium chloride buffer. For both sets 1 denotes noncentrifuged
under ambient light, 2 denotes noncentrifuged, 3 denotes centrifuged sample under ambient light and, 4 denotes
centrifuged sample under 365 nm UV light.

Shown in Figure 24, the sample changes from a deep red (before centrifugation)
to a light brown after centrifugation. The weaker fluorescence seen in Figure 21B can
be attributed to the lower concentration of gold nanoclusters embedded in the protein; as
centrifugation removed a large number of particles from the sample. This difference might
also be attributed to the ionic strength of the buffer used, which could affect the formation
of the clusters in the protein due to shielding with the ions. Dynamic light scattering (DLS)
was also used to show the change in size upon centrifugation. Figure 24A shows that
when deionized water quenched protein nanoparticles are used to make Au-nBSA, the
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size of the particles shows a trimodal, broad set of sizes. When 100 mM phosphate, 500
mM sodium chloride buffer is used to quench the protein nanoparticle synthesis, the size
becomes more defined (Figure 24B). To further attempt to control the size, the incubation
temperature will be manipulated.
The absorbance spectrum obtained from the quenched particles show little to no
peak in the SPR band for gold (Figure 25A), which is consistent with literature.48 The lack
of an SPR band is indicative of the gold nanoclusters embedded in the protein being less
than 3 nm.
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A)

B)

Figure 25: A) Absorbance spectra of Au-nBSA made in either deionized water (red) or 100 mM phosphate, 500 mM
sodium chloride buffer (blue). B) Emission spectra of Au-nBSA quenched with Deionized water (red) and Au-nBSA
quenched with 100 mM, 500 mM sodium chloride buffer (blue). Excitation wavelength = 470 nm.

Fluorescence spectroscopy was used to determine the sizes of the gold clusters
embedded in the protein using the spherical jellium model E emission = Efermi/N1/3. To do
ℎ𝑐

this, Eemission and EFermi need to be converted to wavelengths using E = 𝜆 .49 In this model,
the Fermi wavelength for gold is 0.7 nm.49

Using the peak wavelengths from the

fluorescence data (Figure 25B), the clusters sizes for BSA protected gold nanoclusters in
water and in 100 mM phosphate, 500 mM sodium chloride buffer are ~10 atoms per
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cluster. 10 atoms per cluster is bigger than those reported in literature (25 atoms/cluster
is common)40, indicating that the cross-linked protein nanoparticles may change the
availability of the amino acid side chains that the clusters are sequestered around.

A)

B)

Figure 26: Agarose gel of Au-nBSA. Lane 1: Au-nBSA, Lane 2: nBSA, Lane 3: BSA. A) shows gel under 365 nm UV
light. B) shows gel after Coomassie Blue stain for 24 hours.

Agarose gel electrophoresis was used to ensure that the gold nanoclusters are
actually being formed with the protein. Figure 24 shows that the protein band and the
fluorescence associated with the nanoclusters each traveled the same distance,
indicating that they are either in close proximity to each other or that they are attached.
The clear spot seen in lane 1 of Figure 24B is due to overloading of the gel.
The DLS spectra of the particles show that there is a wide size distribution when
initially synthesized (Figure 23 A and C). To remedy this the samples were centrifuged
at 11,000 rpm for 20 minutes to remove the large particles.
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After centrifugation, the

particles quenched with deionized water showed a trimodal distribution (Figure 23B).
Using a higher ionic strength solution to quench the protein nanoparticles significantly
decreased the size distribution (Figure 23D), although the size is larger than what is
considered to be a nanoparticle, making it not useful for drug delivery.50

A)

C)

B)

D)

Figure 27:A) Au-nBSA particles made in Deionized water before centrifugation. B) Au-nBSA particles made in
Deionized water after 15 minutes centrifugation at 11,000 rpm. C) Au-nBSA particles made in 100 mM phosphate,
500 mM salt buffer before centrifugation. D) Au-nBSA particles made in 100 mM, 500 mM sodium chloride buffer after
centrifugation.
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3.4 Conclusions

Based on the data accumulated, it is possible to apply the nanoparticle synthesis
method to other systems, showing its versatility. The nanoparticles synthesized in this
work were in good agreement with the photophysical data previously described in
literature. By changing the ionic strength of the solution or the incubation temperature
of the synthesis it is possible to control the size distribution of the particles.
Furthermore, changes to the pH and to the temperature of the reaction can be used
to control the number of atoms per cluster.

To fully understand the mechanism

behind the formation of nanoclusters and how to control the synthesis of Au-nBSA,
more work needs to be done.
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